269 related articles for article (PubMed ID: 35909535)
1. Roles of osteocytes in phosphate metabolism.
Michigami T
Front Endocrinol (Lausanne); 2022; 13():967774. PubMed ID: 35909535
[TBL] [Abstract][Full Text] [Related]
2. Osteocytes and the pathogenesis of hypophosphatemic rickets.
Yamazaki M; Michigami T
Front Endocrinol (Lausanne); 2022; 13():1005189. PubMed ID: 36246908
[TBL] [Abstract][Full Text] [Related]
3. Osteocyte-specific deletion of Fgfr1 suppresses FGF23.
Xiao Z; Huang J; Cao L; Liang Y; Han X; Quarles LD
PLoS One; 2014; 9(8):e104154. PubMed ID: 25089825
[TBL] [Abstract][Full Text] [Related]
4. Bone mineralization is regulated by signaling cross talk between molecular factors of local and systemic origin: the role of fibroblast growth factor 23.
Sapir-Koren R; Livshits G
Biofactors; 2014; 40(6):555-68. PubMed ID: 25352227
[TBL] [Abstract][Full Text] [Related]
5. Distinct roles for intrinsic osteocyte abnormalities and systemic factors in regulation of FGF23 and bone mineralization in Hyp mice.
Liu S; Tang W; Zhou J; Vierthaler L; Quarles LD
Am J Physiol Endocrinol Metab; 2007 Dec; 293(6):E1636-44. PubMed ID: 17848631
[TBL] [Abstract][Full Text] [Related]
6. Growth-related skeletal changes and alterations in phosphate metabolism.
Michigami T; Tachikawa K; Yamazaki M; Nakanishi T; Kawai M; Ozono K
Bone; 2022 Aug; 161():116430. PubMed ID: 35577326
[TBL] [Abstract][Full Text] [Related]
7. Emerging role of fibroblast growth factor 23 in a bone-kidney axis regulating systemic phosphate homeostasis and extracellular matrix mineralization.
Liu S; Gupta A; Quarles LD
Curr Opin Nephrol Hypertens; 2007 Jul; 16(4):329-35. PubMed ID: 17565275
[TBL] [Abstract][Full Text] [Related]
8. Sclerostin antibody improves phosphate metabolism hormones, bone formation rates, and bone mass in adult Hyp mice.
Carpenter KA; Davison R; Shakthivel S; Anderson KD; Ko FC; Ross RD
Bone; 2022 Jan; 154():116201. PubMed ID: 34537437
[TBL] [Abstract][Full Text] [Related]
9. Bone proteins PHEX and DMP1 regulate fibroblastic growth factor Fgf23 expression in osteocytes through a common pathway involving FGF receptor (FGFR) signaling.
Martin A; Liu S; David V; Li H; Karydis A; Feng JQ; Quarles LD
FASEB J; 2011 Aug; 25(8):2551-62. PubMed ID: 21507898
[TBL] [Abstract][Full Text] [Related]
10. Pathogenic role of Fgf23 in Hyp mice.
Liu S; Zhou J; Tang W; Jiang X; Rowe DW; Quarles LD
Am J Physiol Endocrinol Metab; 2006 Jul; 291(1):E38-49. PubMed ID: 16449303
[TBL] [Abstract][Full Text] [Related]
11. Parathyroid hormone receptor signaling in osteocytes increases the expression of fibroblast growth factor-23 in vitro and in vivo.
Rhee Y; Bivi N; Farrow E; Lezcano V; Plotkin LI; White KE; Bellido T
Bone; 2011 Oct; 49(4):636-43. PubMed ID: 21726676
[TBL] [Abstract][Full Text] [Related]
12. Conditional Deletion of Murine Fgf23: Interruption of the Normal Skeletal Responses to Phosphate Challenge and Rescue of Genetic Hypophosphatemia.
Clinkenbeard EL; Cass TA; Ni P; Hum JM; Bellido T; Allen MR; White KE
J Bone Miner Res; 2016 Jun; 31(6):1247-57. PubMed ID: 26792657
[TBL] [Abstract][Full Text] [Related]
13. In vitro regulation of fibroblast growth factor 23 by 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D synthesized by osteocyte-like MC3T3-E1 cells.
Ratsma DMA; Muller M; Koedam M; Zillikens MC; van der Eerden BCJ
Eur J Endocrinol; 2023 Oct; 189(4):448-459. PubMed ID: 37796032
[TBL] [Abstract][Full Text] [Related]
14. Regulation of phosphate homeostasis by PTH, vitamin D, and FGF23.
Bergwitz C; Jüppner H
Annu Rev Med; 2010; 61():91-104. PubMed ID: 20059333
[TBL] [Abstract][Full Text] [Related]
15. Pathogenic role of Fgf23 in Dmp1-null mice.
Liu S; Zhou J; Tang W; Menard R; Feng JQ; Quarles LD
Am J Physiol Endocrinol Metab; 2008 Aug; 295(2):E254-61. PubMed ID: 18559986
[TBL] [Abstract][Full Text] [Related]
16. Glucocorticoids dexamethasone and prednisolone suppress fibroblast growth factor 23 (FGF23).
Feger M; Ewendt F; Strotmann J; Schäffler H; Kempe-Teufel D; Glosse P; Stangl GI; Föller M
J Mol Med (Berl); 2021 May; 99(5):699-711. PubMed ID: 33517471
[TBL] [Abstract][Full Text] [Related]
17. Paracrine and endocrine functions of osteocytes.
Michigami T
Clin Pediatr Endocrinol; 2023; 32(1):1-10. PubMed ID: 36761497
[TBL] [Abstract][Full Text] [Related]
18. A Phex mutation in a murine model of X-linked hypophosphatemia alters phosphate responsiveness of bone cells.
Ichikawa S; Austin AM; Gray AK; Econs MJ
J Bone Miner Res; 2012 Feb; 27(2):453-60. PubMed ID: 22006791
[TBL] [Abstract][Full Text] [Related]
19. Dysregulated gene expression in the primary osteoblasts and osteocytes isolated from hypophosphatemic Hyp mice.
Miyagawa K; Yamazaki M; Kawai M; Nishino J; Koshimizu T; Ohata Y; Tachikawa K; Mikuni-Takagaki Y; Kogo M; Ozono K; Michigami T
PLoS One; 2014; 9(4):e93840. PubMed ID: 24710520
[TBL] [Abstract][Full Text] [Related]
20. Sclerostin Directly Stimulates Osteocyte Synthesis of Fibroblast Growth Factor-23.
Ito N; Prideaux M; Wijenayaka AR; Yang D; Ormsby RT; Bonewald LF; Atkins GJ
Calcif Tissue Int; 2021 Jul; 109(1):66-76. PubMed ID: 33616712
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]